# Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules

> **NCT00906503** · PHASE1 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 9 (actual)

## Conditions studied

- Pulmonary Nodule

## Interventions

- **DRUG:** dexamethasone
- **PROCEDURE:** PET/Computed Tomography (CT)
- **RADIATION:** fludeoxyglucose (18F)

## Key facts

- **NCT ID:** NCT00906503
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-02
- **Final completion:** 2012-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2015-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906503, "Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00906503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*